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Four monoclonal antibodies that Inhibited ADP-ribosylation of 23 kDa protem(s) of ascidian eggs catalyzed by Clostrrdium borulrrnrm ADP- 
nbosyltransferase C3 were produced. They also mhibited C3-catalyzed ADP-ribosylatlon of the 24 kDa protein of rat liver cytosol. By the 
immunoprecipltatlon technique. it was found that they recognized small GTP-bindmg protems of ascidlan eggs and mammalian brains, but did 
not Interact with the rat bram activator of the ADP-rlbosyltransferase reaction. The antlbody can also lmmunoprecipitate recombmant Rho A 
Irrespective as to whether the Rho A is the GDP-bound form or the GTPrS-bound form. Thus the antibodies are novel and useful tools m analyzing 
the physiological roles of the Rho fatmly of GTP-bmdmg proteins. 
ADP-nbosylation: GTP-bindmg protein; Monoclonal antlbody: C/oJtr&um botulrnurn: C3 
1. INTRODUCTION 
Rho and related proteins, members of the Ras super- 
family of GTP-binding proteins [1,2], are specifically 
ADP-ribosylated by botulinum exoenzyme C3 pro- 
duced by Clostridiurn botulinurn type C or D [3,4] and 
also by the epidermal cell differentiation inhibitor 
(EDIN) produced by Stuplzylococcus uureus [5]. Physio- 
logical roles of Rho have been investigated by microin- 
jection into several cells or by treatment of the cells 
using botulinum exoenzyme C3 [6-91, constitutively ac- 
tive or dominant negative recombinants of Rho [lo-121 
and an inhibitory GDP/GTP exchange protein of Rho 
(rho GDI) [9,13,14]. Results suggest that Rho regulates 
actin stress fiber formation. With respect to the roles of 
Rat, a Rho-related protein, it is proposed that Rat 
regulates actin membrane rufIling [15] and also plays a 
role in the activation complex of NADPH oxidase [16]. 
On the other hand, one of the authors (T.K.) [17] 
reported the presence of the endogenous botulinum C3- 
like enzyme that catalyzes ADP-ribosylation of small 
GTP-binding proteins, which suggests the possibility 
that the functions of the small GTP-binding proteins 
might be regulated through endogenous ADP-ribosyla- 
tion although little is known about the mechanisms 
under physiological circumstances. 
In this study, we report on the production of mono- 
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clonal antibodies that inhibit ADP-ribosylation of small 
GTP-binding proteins catalyzed by botulinum exoen- 
zyme C3 and present evidence that the antibodies recog- 
nize the small GTP-binding proteins. To our knowl- 
edge, this is the first report on such specific monoclonal 
antibodies directed against the small GTP-binding pro- 
teins. The antibodies are expected to be useful tools to 
analyze the physiological roles of the Rho family of 
GTP-binding proteins. 
2. MATERIALS AND METHODS 
2.1 hlaterruls 
Unfertilized eggs of the ascldian. Halocynthia roretzl, were collected 
as described previously [18]. Botulinum exoenzyme C3 was purified 
from the culture supernatant of C hotulinurn strain D-1873 as de- 
scribed previously [19]. Protem G-agarose was purchased from Sigma 
(St. Louis, MO, USA). Anti-mouse IgG was from Vector Laborato- 
ries. Inc. (Burhngdme. CA, USA). [“PINAD (800 Cl/mmol) was from 
New England Nuclear. 
Egg membrane preparations and a partially-purified preparation of 
small GTP-bmding protem, both of which were used for Immuniza- 
tion, were prepared as follows, ascidlan unfertlhzed eggs were homog- 
enized in 20 mM Tris-HCI (pH 8.0). contammg 5 mM MgCl:. 1 mM 
dlthlothreltol (DTT). 1 mM EDTA. 0.001 mM GDP. 0.01 mM diiso- 
propylfluorophosphate and 0.1 mM leupeptin The homogenate was 
centrifuged at 800 x g for 10 mm and at 10.000 x g for 30 min and the 
resulting preclpltate was used as the membrane preparation. The 
membrane preparation was then solubilized with 1% CHAPS and the 
supernatant obtamed after centrlfugation (100.000 x g, 1 h) was re- 
ferred to as the CHAPS extract. The extract was applied to a QAE- 
Sephadex A-50 (Pharmacia) column previously equlhbrated with 20 
mM Tris-HCI (pH 7 5) contammg 5 mM MgCI,. 1 mM DTT. 1 mM 
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EDTA and 0.005% Lubrol PX The column was washed with the 
equthbration buffer and eluted by mcreasmg the NaCl concentration 
to 0.3 M. The NaCl-eluted fraction was used as a preparation of small 
GTP-binding protem. 
The egg membrane preparation was emulsified with an equal vol- 
ume of Freund’s complete adJuvant and InJected mtraperttoneally mlo 
female Balb/c mice (0 2 mg membrane protem/ammal) An imttal 
mJectton was followed by two mtraperttoneal boostcra of partially 
purified small GTP-bmdmg protein 10.2 mg ofprotem) emulsified with 
an equal volume of Freund’s mcomplete adJuvant at ?-weeh mtervals. 
On the third day after the final tmmumzation. the spleen cells were 
harvested and fused wtth myeloma cell5 (strain P3X63-Ag8.653) by 
standard polyethylene glycol method [IO] Hybndoma cells thus ob- 
tained were cultured at 37°C under 7% CO, m RPM1 1640 medium 
(Nissui Pharmaceutical Co., Tokyo) containmg 10% fetal calf serum 
(Whittaker Btoproducts, Inc Walkersville. MA. USA) 
Anttbody productton was checked on the basis of mhibttton of 
ADP-rtbosylatton of the asctdian egg small GTP-bmdmg protein cat- 
alyzed by botuhnum cxoenzyme C3. Culture medium of hybrtdoma 
cells vvas mixed with an equal volume of the CHAPS extract of asctd- 
tan eggs. incubated at 20°C for 1 h, and then added to the reaction 
mixture consisting of 10 mM Tris-HCI (pH 8 0). IO mM thymidmc. 
1 mM EDTA. I mM DTT. I 5 mM MgCI:. 0.001 mM [“PINAD and 
0 001 mg/ml ewoenzyme C3 in a final volume of 0.04 ml. After incuba- 
tion at 25°C for I h. the reaction was termmated by the addition of 
0.1 ml of 0 I M Trts-HC1 (pH 8 0) contammg 0 5% SDS and 5 mg/ml 
BSA. followed by I ml of 5% trtchloroacetic acid (TC.4) Precipitates 
were filtered through a GF/C filter (Whdtman) and the tilter was 
extensively washed with 5% TCA. Radioactivtty remammg on the 
filter was measured by hqutd scintillation countmg. Hybrtdoma cells. 
culture medta of which mhtbtted the incorporation ?f radioacttvity 
mto the TCA-msoluble fraction, were referred to as positive ones. and 
subJected to limiting dilution for clonmg of positive cell lines. Four 
antibody-producmg clones (A5. Cd. C7 and G5) were established. 
Subclasses of monoclonal antibodies were determmed usmg the 
mouse monoclonal antibody tsotypmg ktt (Amersham) according to 
manufacturer’s protocol. 
Amounts of monoclonal antibodtes contamcd m the culture media 
were measured by a sandwich enzyme-linked tmmunosorbent assay 
(ELISA) as follows; purified immunoglobulm G (IgG) against mouse 
IgG (antt-mouse IgG. Vector) (0 01 mg/ml) was adsorbed to a 96-well 
ELISA plate after standmg at 4°C overmght .4fter uashmg and 
blockmg. culture medium was added to the well and the plate was kept 
standmg at room temperature for 2 h. After washing. biotm-conJu- 
gated anti-mouse IgG (Vector) and then avtdinbtotmylated perorit- 
dase complex were added to the well and incubated at room tcmpera- 
ture for 2 h and for 30 mm, respectively The color was developed 
usmg 0.02% H,O, and 0 2 mg/ml1.2’-azmobia(3-ethylbenzothtazohne- 
6-sulfonic acid) as substrates 
SDS-polyacrylamide gel electrophorests (SDS-PAGE) was carried 
out accordmg to the method of Laemmli [21] for determmation of the 
molecular weight of the C3 substrate that was ADP-nbosylated by 
exoenzyme C3. Gels were stained with Coomasste brilhant blue and 
subJected to autoradiography 
tlw .4 DP-r~hos~lrrcn~,\~/crtr.sr YP(ICIIOII 
Preparation of small GTP-bmding proteins (C3 substrates) from 
ascidtan eggs IS described m detail elsewhere. Briefly. the CHAPS 
extract was successively subjected to four chromatographies on col- 
umns of DEAE-Toyopearl (Tosoh), phenyl-Sepharose CL-4B (Phar- 
macia), hydroxylapattte (Pentax) (HPLC). and Mono Q (Pharmacta) 
(FPLC) Small GTP-binding proteins were momtored by C3-catalyzed 
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ADP-rtbosylatton. The ADP-ribosyltransferase reaction of the final 
purified preparation obtamed from the Mono Q column did not re- 
quire the presence of any actuator. 
Small GTP-bmdtng proteins (C3 substrates) and activator(s) of the 
ADP-rtbosyltransferase reaction were prepared from rat bram as de- 
scribed previously [??I. Rat brain was homogenized m 10 mM Trts- 
HCI (pH 7 5) contammg 10% sucrose and 0.01 mM leupeptm and the 
homogenate was centrifuged at IO.000 xfi for 30 mm and at 
100,000 x !: for 60 mm The rcrulting supernatant (cytosol) was sub- 
Jectcd to a DEAE-Toyopearl 650M column previously equthbrated 
with IO mM Tris-HCI (pH 7 5) contannng 10% sucrose. 0.01 mM 
leupeptm. I mM MgCI, and 20 mM NaCI. After washing, the column 
was eluted with a 20~ 300 mM NaCl linear gradtent in equihbration 
buffer The GTP-bmding protem was eluted at 50 mM NaCI. while 
the activator elutcd around 200 mM NaCl Both preparations were 
used for Immunnprrclpltatlon experiments. 
Rat hver cytosol was prepared accordmg to the method used for the 
preparation of rat bram cytosol as described above. Purified C3 sub- 
strate GTP-bmding protem was prepared from bovme brain as de- 
scribed prevtoualy [23] Recombmant Rho A was purtfied from the 
soluble frdctton of Evc/)~rc~/rr~r (.I,// In which Rho A was overexpressed 
using a plasmid. pGEX-2T rho A [13]. The purified C3 substrate and 
recombmant Rho A proteins were purtfied as GDP-bound forms. 
Where indicated. GTPrS-bound form of the recombmant Rho A was 
prepared by incubation with 0.07 mM GTPrS at 30°C for 30 mm m 
a reactton mtxture contatnmg 0.003 mM MgCI, [33] The plasmtd and 
cDNA of r/?~ A were kmdly provided by Drs. Y Tdkai (Kobe Univer- 
sity School of Medictnc. Japan) and P. Madame (Centre National de 
la Rccherchc Scicntilique Laboratone. GIN wr Yvette. France) 
Anti-mouse IgG was diluted to 0 I mgiml atth 20 mM Tns-HCI (pH 
8 5) contaming 0.15 M NdCI. mired with protem G-agarose (the 
swollen volume was dpproxnnately 0.05 ml) and incubated at room 
temperature for 4 h. Monoclonal antibody solutton (0.005 mg/ml) was 
added to the gel recovered by centrtfugation and incubated at room 
temperature for 3 h. The gel was vvashed with the buffer by centrtfuga- 
tion and used as a cornpIe\ conststmg of monoclonal antibody. anti- 
mouse IgG and protem G-agarose. 
The gel was added to etthcr the small GTP-binding protein (C3 
substrate) preparation or to the activator preparatton and the mixture 
was incubated at 1°C‘ overmght. After the gel was removed by centrtf- 
ugatton, the resulting aupernitant was recovered The remaimng 
amounts in the supernatants of the GTP-bindmg protein and the 
activator were determined by C?-catalyzed ADP-rtbosylation after the 
addition of a suflicient amount of the activator and a defined amount 
of the GTP-bmding protcm. rcspecttvely 
3. RESULTS AND DISCUSSION 
By screening on the basis of inhibition of ADP-ri- 
bosylation of small GTP-binding proteins catalyzed by 
botulinum exoenzyme C3, we succeeded in establishing 
four hybridoma ccl1 clones producing monoclonal anti- 
bodies that inhibit C3-catalyzed ADP-ribosylation. 
Table I 
Established hybrtdoma clones producmg monoclonal antibodies that 
mhtbit C3-catalyzed ADP-ribosylation ofsmall GTP-bmdmgprotems 
Clone 
A5 
C4 
Cl 
G5 
Subclass 
lgG3 
IgG?b 
lgG3 
IgG’b 
Light cham 
lambda 
kappa 
kappa 
kappa 
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SDS-PAGE 
- - 45K 
- 26K 
- 17K 
Autoradiography 
- 23K 
Control A5 
Ftg. 1. Inhibition by monoclonal antibody A5 of C3-catalyzed ADP- 
rtbosylation of 23 kDa protein of ascidtan egg membrane. The 
CHAPS extract was prevtously incubated with A5 antibody or control 
IgG, and the ADP-rtbosylation reactton was carried out. The reactton 
mixture was then subjected to SDS-PAGE, followed by autoradiogra- 
phy. 
Four monoclonal antibodies were classified as IgG 
(Table I). An autoradiogram (Fig. 1) shows that the 
botulinurn exoenzyme C3 catalyzed ADP-ribosylation 
of small GTP-binding protein(s) of ascidian eggs has a 
molecular mass of 23 kDa and that the monoclonal 
antibody (A5) inhibited ADP-ribosylation. 
I 
G5 
i I I 
.l 1 10 
G5 @g/ml) 
C4 &g/ml) 
Fig. 2 shows dependency on the antibody concentra- 
tion of its inhibition of C3-catalyzed ADP-ribosylation 
of GTP-binding proteins of ascidian egg membrane and 
rat liver cytosol (in the latter case, exoenzyme C3 ADP- 
ribosylated a 24 kDa protein). Any antibody inhibited 
the ADP-ribosylation of the two GTP-binding proteins 
in a similar concentration-dependent manner. When re- 
combinant Rho A was used as a C3 substrate. the same 
results were obtained (data not shown). 
To define antigen molecule(s) that are recognized by 
the monoclonal antibodies thus prepared, we used them 
for Western blot analysis by the method of Towbin et 
al. [25]. But, however, no detectable signs were ob- 
served, indicating that the antibodies are unable to react 
with the antigen(s) previously treated with 1% SDS. 
Thus the antibodies may recognize the gross structure 
of the antigen. 
One of the authors [22] previously reported the pres- 
ence in bovine brain of activator(s) that activate ADP- 
ribosyltransferase reaction catalyzed by exoenzyme C3. 
Since we used the CHAPS extract of ascidian eggs as a 
C3 substrate for the ADP-ribosyltransferase reaction 
during screening of hybridoma cells, two possibilities of 
the mechanisms through which the antibodies inhibit 
C3-catalyzed ADP-ribosylation of small GTP-binding 
proteins can be considered. One is the possibility that 
the antibody inhibits the ADP-ribosyltransferase reac- 
tion through its binding to an ADP-ribosylation site on 
A5 
100 
A5 @g/ml) 
I 
.l 1 10 
C7 @g/ml) 
Fig. 2. Inhtbition by monoclonal antibodies G5. A5. C4 and C7 of C3-catalyzed ADP-rtbosylatlon usmg ascidtan egg CHAPS extract (0) and rat 
liver cytosol (0) as C3 substrates. The CHAPS extract or the cytosol was prevtously Incubated wtth each monoclonal antibody and subjected to 
the ADP-ribosylation reaction. After termmatton by the additton of 0.5% SDS and then 5% TCA. the prectpltates were filtered through a GFK 
filter. Radioacttvity remaming on the filter was measured. The value m the absence of antibody was defined as 100%. 
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Table II 
Immunoprecipitation with monoclonal antibodies 
Preparation Amount m the supernatant (%) 
Con- A5 C4 C7 G5 
trolb 
(a) Ascidian egg preparation 
I. Small GTP-bmdmg protein too 32 47 35 53 
(b) Rat brain preparation 
I Small GTP-bmdmg protem 100 38 64 59 72 
2 Activator 100 95 97 96 98 
(c) C3 substrate GTP-bindmg 
Protem from bovine bram 100 45 70 48 74 
(d) Recombinant Rho A 
1. GDP-bound form 
2. GTPrS-bound form 
100 33 ~ ~ 
100 56 -- ~ 
Each preparation was immunoprecipitated with either of monoclonal 
antibodies and the amount remaining m the supernatant was meas- 
ured as described in section 2. 
“The amount m the presence of control IgG was defined as 100%. 
hControl mouse IgG. 
the small GTP-binding protein, while the other is that 
it inhibits activation of the reaction through its binding 
to the activator. To clarify this point, we investigated 
which of the GTP-binding proteins or the activators can 
be immunoprecipitated by the antibody (Table II). In 
the case of ascidian eggs, we did not succeed in separat- 
ing the GTP-binding protein from the activator al- 
though high purification of the former was achieved. 
However, an immunoprecipitation experiment with as- 
cidian egg GTP-binding protein, ADP-ribosylation of 
which is not required for the presence of the activator, 
shows that four monoclonal antibodies can im- 
munoprecipitate the GTP-binding protein (Table IIa). 
Next, we tried to isolate the small GTP-binding pro- 
tein(s) and the activator from rat brain cytosol. The 
DEAE-Toyopearl chromatography gave a good separa- 
tion between them. When the former was immunopre- 
cipitated with the antibody, the remaining amount of 
the former in the supernatant was decreased (Table IIb). 
On the other hand, the remaining amount of the latter 
remained unchanged after immunoprecipitation. Thus 
the four monoclonal antibodies can recognize the small 
GTP-binding protein. but did not interact with the acti- 
vator. 
Finally, we confirmed the immunoreactivity of the 
monoclonal antibody with the small GTP-binding pro- 
tein using pure C3 substrate GTP-binding protein of 
bovine brain (Table 11~) and recombinant Rho A (Table 
IId). In fact, four monoclonal antibodies can im- 
munoprecipitate the pure C3 substrate GTP-binding 
protein. Furthermore, the antibody A5 can immunopre- 
cipitate either the GDP-bound form or GTPrS-bound 
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form of the recombinant Rho A, although it seems that 
the antibody can interact with the former form a little 
stronger than the latter. In conclusion, the monoclonal 
antibodies prepared in this study can recognize epitopes 
of the Rho family of GTP-binding proteins, common 
from the protochordates to the mammals. 
It has been reported that Asn” of Rho is ADP-ri- 
bosylated by exoenzyme C3 [36]. Since this site is 
thought to be located in the putative effector domain of 
Rho, it is likely that the monoclonal antibody prepared 
in this study can block the interaction between Rho and 
its regulatory proteins such as rho GAP. Alternatively, 
it may inhibit putative endogenous ADP-ribosylation of 
Rho. In our preliminary experiments, microinjection of 
this monoclonal antibody into ascidian egg resulted in 
the inhibition of egg activation and fertilization, which 
suggests the involvement of Rho or Rho-related pro- 
teins in these phenomena. Thus the antibodies are novel 
and useful tools to analyze the functions of Rho and 
related proteins. 
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